PDE1 |
PDE1A |
cAMP/cGMP |
Cytosolic |
β2-AR |
8-methoxymethyl-IBMX; vinpocetine; nimodipine; IC86340; IC295; |
[65–67] |
|
PDE1B |
|
|
|
|
|
|
PDE1C |
|
|
|
|
|
PDE2 |
PDE2A |
cAMP/cGMP |
Membrane or cytosolic, mitochondria |
EP2 β2-AR |
BAY 60-7550; PDP; EHNA; IC933; oxindole; ND-7001; |
[55,68] |
PDE3 |
PDE3A |
cAMP/cGMP |
Membrane or cytosolic |
β2-AR |
Olprinone; cilostamide; milronone; cilostazol; milrinone; siguazodan; enoximone; motapizone; SK&F94120; org9935; |
[26,69] |
|
PDE3B |
|
|
|
|
|
PDE4 |
PDE4A |
cAMP |
Membrane or cytosolic |
EP2 |
Rolipram; roflumilast; cilomast; RP73401; Ro20–1724; CHF6001; GPD-1116; ASP3258; YM976; |
[70–72] |
|
PDE4B |
|
|
|
|
|
|
PDE4C |
|
|
|
|
|
|
PDE4D |
|
|
|
|
|
PDE5 |
PDE5A |
cGMP |
Cytosolic |
β2-AR |
Zaprinast; DMPPO; sildenafil; tadalafil; vardenafil; dipyridamole; E4021; avanafil; |
[73] |
PDE6 |
PDE6A |
cGMP |
Cytosolic |
β2-AR |
Zaprinast; DMPPO; sildenafil; vardenafil; |
[74] |
|
PDE6B |
|
|
|
|
|
|
PDE6C |
|
|
|
|
|
|
PDE6D |
|
|
|
|
|
PDE7 |
PDE7A |
cAMP |
Cytosolic |
β2-AR |
BRL 50481; IC242; T-2585; compound 21a; |
[75] |
|
PDE7B |
|
|
|
|
|
PDE8 |
PDE8A |
cAMP |
Membrane or cytosolic, mitochondria |
β2-AR |
PF-4957325; dipyridamole; |
[62•] |
|
PDE8B |
|
|
|
|
|
PDE9 |
PDE9A |
cGMP |
Cytosolic or nuclear |
β2-AR |
BAY-73–6691; PF-04447943; |
[76] |
PDE10 |
PDE10A |
cAMP/cGMP |
Cytosolic |
β2-AR |
Papaverine; TP-10; MP-10 (PF-2545920); |
[77] |
PDE11 |
PDE11A |
cAMP/cGMP |
Cytosolic |
β2-AR |
BC11-38; |
[78] |